Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2021

Open Access 01-12-2021 | Lymphoma | Case report

Pulmonary infiltration as the initial manifestation of chronic lymphoproliferative disorder of natural killer cells: a case report and literature review

Authors: Jinjing Zhang, Pingping Wang, Xiaojing Yan

Published in: BMC Pulmonary Medicine | Issue 1/2021

Login to get access

Abstract

Background

Chronic lymphoproliferative disorder of natural killer cells (CLPD-NK) is an extremely rare haematological disease. To the best of our knowledge, pulmonary infiltration in CLPD-NK has not been reported before. Our case study aimed to present the clinical characteristics, chest computed tomography (CT) findings, and flow cytometry immunophenotyping (FCI) results of an unusual case of migratory pulmonary infiltration in a patient with CLPD-NK.

Case presentation

A 51-year-old female patient was admitted to our hospital on October 8, 2019. Eight months before this visit, she had been diagnosed with pneumonia in a community hospital with 1 month of low-grade fever and had recovered after oral antibiotic administration. During follow-up, the patient presented with persistent peripheral blood (PB) lymphocytosis and ground-glass opacities on lung CT scans without any symptoms and signs or any evidence of infectious, allergic or autoimmunity pulmonary diseases. Abnormal NK cells were identified in the PB, bone marrow and bronchoalveolar lavage fluid (BALF) using FCI in our hospital. Eventually, the patient was diagnosed with pulmonary infiltration of CLPD-NK. The patient had an indolent clinical course without symptoms, hepatosplenomegaly or palpable lymphadenopathy and did not receive any therapy. The patient has remained in a good performance status 13 months after the diagnosis.

Conclusions

Our study described a unique case of pulmonary infiltration in a patient with CLPD-NK. The present case highlights the importance of FCI of the BALF in patients with lymphocytosis and pulmonary shadows to avoid misdiagnosis.
Literature
1.
go back to reference Lamy T, Moignet A, Loughran TP Jr. LGL leukemia: from pathogenesis to treatment. Blood. 2017;129(9):1082–94.CrossRef Lamy T, Moignet A, Loughran TP Jr. LGL leukemia: from pathogenesis to treatment. Blood. 2017;129(9):1082–94.CrossRef
2.
go back to reference Kurt H, Jorgensen JL, Amin HM, Patel KP, Wang SA, Lin P, Kanagal-Shamanna R, Loghavi S, Thakral B, Khogeer HA, et al. Chronic lymphoproliferative disorder of NK-cells: a single-institution review with emphasis on relative utility of multimodality diagnostic tools. Eur J Haematol. 2018;100(5):444–54.CrossRef Kurt H, Jorgensen JL, Amin HM, Patel KP, Wang SA, Lin P, Kanagal-Shamanna R, Loghavi S, Thakral B, Khogeer HA, et al. Chronic lymphoproliferative disorder of NK-cells: a single-institution review with emphasis on relative utility of multimodality diagnostic tools. Eur J Haematol. 2018;100(5):444–54.CrossRef
3.
go back to reference Poullot E, Zambello R, Leblanc F, Bareau B, De March E, Roussel M, Boulland ML, Houot R, Renault A, Fest T, et al. Chronic natural killer lymphoproliferative disorders: characteristics of an international cohort of 70 patients. Ann Oncol. 2014;25(10):2030–5.CrossRef Poullot E, Zambello R, Leblanc F, Bareau B, De March E, Roussel M, Boulland ML, Houot R, Renault A, Fest T, et al. Chronic natural killer lymphoproliferative disorders: characteristics of an international cohort of 70 patients. Ann Oncol. 2014;25(10):2030–5.CrossRef
4.
go back to reference Tefferi A, Li CY, Witzig TE, Dhodapkar MV, Okuno SH, Phyliky RL. Chronic natural killer cell lymphocytosis: a descriptive clinical study. Blood. 1994;84(8):2721–5.CrossRef Tefferi A, Li CY, Witzig TE, Dhodapkar MV, Okuno SH, Phyliky RL. Chronic natural killer cell lymphocytosis: a descriptive clinical study. Blood. 1994;84(8):2721–5.CrossRef
5.
go back to reference Rabbani GR, Phyliky RL, Tefferi A. A long-term study of patients with chronic natural killer cell lymphocytosis. Br J Haematol. 1999;106(4):960–6.CrossRef Rabbani GR, Phyliky RL, Tefferi A. A long-term study of patients with chronic natural killer cell lymphocytosis. Br J Haematol. 1999;106(4):960–6.CrossRef
6.
go back to reference Lima M, Almeida J, Montero AG, Teixeira Mdos A, Queirós ML, Santos AH, Balanzategui A, Estevinho A, Algueró Mdel C, Barcena P, et al. Clinicobiological, immunophenotypic, and molecular characteristics of monoclonal CD56-/+dim chronic natural killer cell large granular lymphocytosis. Am J Pathol. 2004;165(4):1117–27.CrossRef Lima M, Almeida J, Montero AG, Teixeira Mdos A, Queirós ML, Santos AH, Balanzategui A, Estevinho A, Algueró Mdel C, Barcena P, et al. Clinicobiological, immunophenotypic, and molecular characteristics of monoclonal CD56-/+dim chronic natural killer cell large granular lymphocytosis. Am J Pathol. 2004;165(4):1117–27.CrossRef
7.
go back to reference Oshimi K, Kawa K, Nakamura S, Suzuki R, Suzumiya J, Yamaguchi M, Kameoka J, Tagawa S, Imamura N, Ohshima K, et al. NK-cell neoplasms in Japan. Hematology (Amsterdam Netherlands). 2005;10(3):237–45. Oshimi K, Kawa K, Nakamura S, Suzuki R, Suzumiya J, Yamaguchi M, Kameoka J, Tagawa S, Imamura N, Ohshima K, et al. NK-cell neoplasms in Japan. Hematology (Amsterdam Netherlands). 2005;10(3):237–45.
8.
go back to reference Jerez A, Clemente MJ, Makishima H, Koskela H, Leblanc F, Peng Ng K, Olson T, Przychodzen B, Afable M, Gomez-Segui I, et al. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia. Blood. 2012;120(15):3048–57.CrossRef Jerez A, Clemente MJ, Makishima H, Koskela H, Leblanc F, Peng Ng K, Olson T, Przychodzen B, Afable M, Gomez-Segui I, et al. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia. Blood. 2012;120(15):3048–57.CrossRef
9.
go back to reference Jiang NG, Jin YM, Niu Q, Zeng TT, Su J, Zhu HL. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood. Ann Hematol. 2013;92(1):89–96.CrossRef Jiang NG, Jin YM, Niu Q, Zeng TT, Su J, Zhu HL. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood. Ann Hematol. 2013;92(1):89–96.CrossRef
10.
go back to reference Peng G, Zhao X, Xiong Y, Li Y, Li Y, Li J, Ye L, Fan H, Song L, Yang W, et al. Chronic natural killer cell lymphocytosis: eight cases report and literature review. Zhonghua xue ye xue za zhi 2014; 35(7):609–13. Peng G, Zhao X, Xiong Y, Li Y, Li Y, Li J, Ye L, Fan H, Song L, Yang W, et al. Chronic natural killer cell lymphocytosis: eight cases report and literature review. Zhonghua xue ye xue za zhi 2014; 35(7):609–13.
11.
go back to reference Gattazzo C, Teramo A, Passeri F, De March E, Carraro S, Trimarco V, Frezzato F, Berno T, Barila G, Martini V, et al. Detection of monoclonal T populations in patients with KIR-restricted chronic lymphoproliferative disorder of NK cells. Haematologica. 2014;99(12):1826–33.CrossRef Gattazzo C, Teramo A, Passeri F, De March E, Carraro S, Trimarco V, Frezzato F, Berno T, Barila G, Martini V, et al. Detection of monoclonal T populations in patients with KIR-restricted chronic lymphoproliferative disorder of NK cells. Haematologica. 2014;99(12):1826–33.CrossRef
12.
go back to reference Li Y, Wei J, Mao X, Gao Q, Liu L, Cheng P, Liu L, Zhang X, Zhang K, Wang J, et al. Flow cytometric immunophenotyping is sensitive for the early diagnosis of de novo aggressive natural killer cell leukemia (ANKL): a multicenter retrospective analysis. PLoS ONE. 2016;11(8):e0158827.CrossRef Li Y, Wei J, Mao X, Gao Q, Liu L, Cheng P, Liu L, Zhang X, Zhang K, Wang J, et al. Flow cytometric immunophenotyping is sensitive for the early diagnosis of de novo aggressive natural killer cell leukemia (ANKL): a multicenter retrospective analysis. PLoS ONE. 2016;11(8):e0158827.CrossRef
13.
go back to reference Liu Y, Wang M, Qiu ZY, Miao Y, Sun Q, Wu YJ, Fan L, Wang L, Xu W, Li JY. Analysis of immunophenotypic and clinical features of 13 patients with chromc lymphoproliferative disorder of NK cells. J Leukemia Lymphoma. 2016;25(5):285–9. Liu Y, Wang M, Qiu ZY, Miao Y, Sun Q, Wu YJ, Fan L, Wang L, Xu W, Li JY. Analysis of immunophenotypic and clinical features of 13 patients with chromc lymphoproliferative disorder of NK cells. J Leukemia Lymphoma. 2016;25(5):285–9.
14.
go back to reference Barilà G, Teramo A, Calabretto G, Ercolin C, Boscaro E, Trimarco V, Carraro S, Leoncin M, Vicenzetto C, Cabrelle A, et al. Dominant cytotoxic NK cell subset within CLPD-NK patients identifies a more aggressive NK cell proliferation. Blood Cancer J. 2018;8(6):51.CrossRef Barilà G, Teramo A, Calabretto G, Ercolin C, Boscaro E, Trimarco V, Carraro S, Leoncin M, Vicenzetto C, Cabrelle A, et al. Dominant cytotoxic NK cell subset within CLPD-NK patients identifies a more aggressive NK cell proliferation. Blood Cancer J. 2018;8(6):51.CrossRef
15.
go back to reference Okuno SH, Tefferi A, Hanson CA, Katzmann JA, Li CY, Witzig TE. Spectrum of diseases associated with increased proportions or absolute numbers of peripheral blood natural killer cells. Br J Haematol. 1996;93(4):810–2.PubMed Okuno SH, Tefferi A, Hanson CA, Katzmann JA, Li CY, Witzig TE. Spectrum of diseases associated with increased proportions or absolute numbers of peripheral blood natural killer cells. Br J Haematol. 1996;93(4):810–2.PubMed
16.
go back to reference Murro D, Slade JM, Gattuso P. Cytologic findings of hematologic malignancies in bronchoalveolar lavage fluid. J Am Soc Cytopathol. 2015;4(5):267–75.CrossRef Murro D, Slade JM, Gattuso P. Cytologic findings of hematologic malignancies in bronchoalveolar lavage fluid. J Am Soc Cytopathol. 2015;4(5):267–75.CrossRef
17.
go back to reference Zhang MC, Zhou M, Song Q, Wang S, Shi Q, Wang L, Yan FH, Qu JM, Zhao WL. Clinical features and outcomes of pulmonary lymphoma: a single center experience of 180 cases. Lung cancer (Amsterdam Netherlands). 2019;132:39–44.CrossRef Zhang MC, Zhou M, Song Q, Wang S, Shi Q, Wang L, Yan FH, Qu JM, Zhao WL. Clinical features and outcomes of pulmonary lymphoma: a single center experience of 180 cases. Lung cancer (Amsterdam Netherlands). 2019;132:39–44.CrossRef
18.
go back to reference Pan Z, Xu ML. T-cell and NK-cell lymphomas in the lung. Semin Diagn Pathol. 2020;37(6):273–82.CrossRef Pan Z, Xu ML. T-cell and NK-cell lymphomas in the lung. Semin Diagn Pathol. 2020;37(6):273–82.CrossRef
19.
go back to reference Choo R, Anantham D. Role of bronchoalveolar lavage in the management of immunocompromised patients with pulmonary infiltrates. Ann Transl Med. 2019;7(3):49.CrossRef Choo R, Anantham D. Role of bronchoalveolar lavage in the management of immunocompromised patients with pulmonary infiltrates. Ann Transl Med. 2019;7(3):49.CrossRef
20.
go back to reference Song JY, Filie AC, Venzon D, Stetler-Stevenson M, Yuan CM. Flow cytometry increases the sensitivity of detection of leukemia and lymphoma cells in bronchoalveolar lavage specimens. Cytometry Part B Clin Cytom. 2012;82(5):305–12.CrossRef Song JY, Filie AC, Venzon D, Stetler-Stevenson M, Yuan CM. Flow cytometry increases the sensitivity of detection of leukemia and lymphoma cells in bronchoalveolar lavage specimens. Cytometry Part B Clin Cytom. 2012;82(5):305–12.CrossRef
Metadata
Title
Pulmonary infiltration as the initial manifestation of chronic lymphoproliferative disorder of natural killer cells: a case report and literature review
Authors
Jinjing Zhang
Pingping Wang
Xiaojing Yan
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2021
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-021-01457-y

Other articles of this Issue 1/2021

BMC Pulmonary Medicine 1/2021 Go to the issue